vs
Apellis Pharmaceuticals, Inc.（APLS）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Ranger Energy Services, Inc.的1.4倍（$199.9M vs $142.2M），Ranger Energy Services, Inc.净利率更高（2.3% vs -29.5%，领先31.7%），Ranger Energy Services, Inc.同比增速更快（-0.6% vs -5.9%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 1.9%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
APLS vs RNGR — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $142.2M |
| 净利润 | $-59.0M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 2.3% |
| 净利率 | -29.5% | 2.3% |
| 营收同比 | -5.9% | -0.6% |
| 净利润同比 | -62.2% | -44.8% |
| 每股收益（稀释后） | $-0.40 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $142.2M | ||
| Q3 25 | $458.6M | $128.9M | ||
| Q2 25 | $178.5M | $140.6M | ||
| Q1 25 | $166.8M | $135.2M | ||
| Q4 24 | $212.5M | $143.1M | ||
| Q3 24 | $196.8M | $153.0M | ||
| Q2 24 | $199.7M | $138.1M | ||
| Q1 24 | $172.3M | $136.9M |
| Q4 25 | $-59.0M | $3.2M | ||
| Q3 25 | $215.7M | $1.2M | ||
| Q2 25 | $-42.2M | $7.3M | ||
| Q1 25 | $-92.2M | $600.0K | ||
| Q4 24 | $-36.4M | $5.8M | ||
| Q3 24 | $-57.4M | $8.7M | ||
| Q2 24 | $-37.7M | $4.7M | ||
| Q1 24 | $-66.4M | $-800.0K |
| Q4 25 | -25.6% | 2.3% | ||
| Q3 25 | 48.7% | 2.0% | ||
| Q2 25 | -18.6% | 6.1% | ||
| Q1 25 | -50.0% | 0.7% | ||
| Q4 24 | -12.3% | 6.2% | ||
| Q3 24 | -24.0% | 8.4% | ||
| Q2 24 | -14.7% | 5.3% | ||
| Q1 24 | -36.0% | -0.4% |
| Q4 25 | -29.5% | 2.3% | ||
| Q3 25 | 47.0% | 0.9% | ||
| Q2 25 | -23.6% | 5.2% | ||
| Q1 25 | -55.3% | 0.4% | ||
| Q4 24 | -17.1% | 4.1% | ||
| Q3 24 | -29.2% | 5.7% | ||
| Q2 24 | -18.9% | 3.4% | ||
| Q1 24 | -38.5% | -0.6% |
| Q4 25 | $-0.40 | $0.14 | ||
| Q3 25 | $1.67 | $0.05 | ||
| Q2 25 | $-0.33 | $0.32 | ||
| Q1 25 | $-0.74 | $0.03 | ||
| Q4 24 | $-0.30 | $0.24 | ||
| Q3 24 | $-0.46 | $0.39 | ||
| Q2 24 | $-0.30 | $0.21 | ||
| Q1 24 | $-0.54 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $300.1M |
| 总资产 | $1.1B | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $10.3M | ||
| Q3 25 | $479.2M | $45.2M | ||
| Q2 25 | $370.0M | $48.9M | ||
| Q1 25 | $358.4M | $40.3M | ||
| Q4 24 | $411.3M | $40.9M | ||
| Q3 24 | $396.9M | $14.8M | ||
| Q2 24 | $360.1M | $8.7M | ||
| Q1 24 | $325.9M | $11.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $93.1M | $0 |
| Q4 25 | $370.1M | $300.1M | ||
| Q3 25 | $401.2M | $270.0M | ||
| Q2 25 | $156.3M | $276.9M | ||
| Q1 25 | $164.2M | $272.6M | ||
| Q4 24 | $228.5M | $273.8M | ||
| Q3 24 | $237.1M | $267.6M | ||
| Q2 24 | $264.3M | $260.5M | ||
| Q1 24 | $266.7M | $261.7M |
| Q4 25 | $1.1B | $419.3M | ||
| Q3 25 | $1.1B | $372.8M | ||
| Q2 25 | $821.4M | $381.7M | ||
| Q1 25 | $807.3M | $376.5M | ||
| Q4 24 | $885.1M | $381.6M | ||
| Q3 24 | $901.9M | $373.9M | ||
| Q2 24 | $904.5M | $359.6M | ||
| Q1 24 | $831.9M | $355.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | 0.35× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $17.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 12.0% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 7.53× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $42.9M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $24.1M | ||
| Q3 25 | $108.5M | $13.6M | ||
| Q2 25 | $4.4M | $20.7M | ||
| Q1 25 | $-53.4M | $10.6M | ||
| Q4 24 | $19.4M | $32.7M | ||
| Q3 24 | $34.1M | $17.7M | ||
| Q2 24 | $-8.3M | $22.1M | ||
| Q1 24 | $-133.0M | $12.0M |
| Q4 25 | $-14.3M | $17.1M | ||
| Q3 25 | $108.3M | $8.0M | ||
| Q2 25 | $4.4M | $14.4M | ||
| Q1 25 | $-53.4M | $3.4M | ||
| Q4 24 | $19.3M | $27.3M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | $-8.4M | $6.8M | ||
| Q1 24 | $-133.3M | $5.5M |
| Q4 25 | -7.1% | 12.0% | ||
| Q3 25 | 23.6% | 6.2% | ||
| Q2 25 | 2.5% | 10.2% | ||
| Q1 25 | -32.0% | 2.5% | ||
| Q4 24 | 9.1% | 19.1% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | -4.2% | 4.9% | ||
| Q1 24 | -77.3% | 4.0% |
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 4.5% | ||
| Q1 25 | 0.0% | 5.3% | ||
| Q4 24 | 0.0% | 3.8% | ||
| Q3 24 | 0.0% | 4.5% | ||
| Q2 24 | 0.0% | 11.1% | ||
| Q1 24 | 0.2% | 4.7% |
| Q4 25 | — | 7.53× | ||
| Q3 25 | 0.50× | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
